Lior Zangi, PhD, is an Associate Professor with Tenure at the Icahn School of Medicine at Mount Sinai, New York
Lior Zangi, PhD, is an Associate Professor with Tenure at the Icahn School of Medicine at Mount Sinai, New York. He completed his education and training at the Weizmann Institute of Science, and Harvard University. Studies modified mRNA (modRNA) therapeutic in the heart to induce cardiac regeneration, protection, or cardiovascular regeneration post ischemic injury. He has established a new method for minimal invasive modRNA delivery into specific cell types and organs. He was the first to deliver modRNA into cardiac and skeletal muscle and his invention led to the first successful phase 2 cardiac modRNA therapeutic clinical trial of Modenra/AstraZeneca (using VEGFA modRNA). Currently, Prof. Zangi’s laboratory investigates mRNA delivery method into healthy or unhealthy specific cell types and organs, to fight different diseases such as heart failure and cancer.